PROLOR Biotech, Inc. 4
4 · PROLOR Biotech, Inc. · Filed Jun 6, 2013
Insider Transaction Report
Form 4
GORECKI MARIAN
Director
Transactions
- Award
Stock Option (right to buy)
2013-06-04+44,000→ 44,000 totalExercise: $4.74Exp: 2023-02-04→ Common Stock (44,000 underlying)
Footnotes (2)
- [F1]On February 4, 2013, the Compensation Committee of the Board of Directors of PROLOR Biotech, Inc. (the "Company") granted the reported options to the Reporting Person subject to stockholder approval of an amendment to the Company's 2007 Equity Incentive Plan at the Company's 2013 Annual Meeting of Stockholders held on June 4, 2013 (the "Annual Meeting"). The Company's stockholders approved such amendment at the Annual Meeting.
- [F2]Option vests in twelve equal monthly installments commencing on March 4, 2013.